NeuroPace Inc

NPCE

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001528287

SEC filings (opens in a new tab)

No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding NeuroPace Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of NPCE: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	24	22	−2
Shares	17.7M	17.5M	−166.6K (−0.9%)
Value	$82.0M	$78.6M	−$3.40M (−4.1%)

New holders (1)

Institutions that held NeuroPace Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to NPCE in Q2 2023
Institution	Shares	Value	% of portfolio
Royal Bank of Canada	341	$2.00K	0.00%

Sold out (3)

Institutions that held NeuroPace Inc at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of NPCE in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
SG Americas Securities, LLC	25,388	$118.0K
Susquehanna International Group, LLP	14,052	$65.2K
UBS Group AG	2,623	$12.2K